Damon Hostin has had an active and exciting journey in genomic medicine. He’s now at Illumina, where his title is illuminative: Lead, Health System Market Access.A regular on the precision medicine stage, Damon has some insights into what he calls the “blindingly fast progression” of genomic medicine that should convince the most jaded of its critics. Compared to other areas of medicine, we are witnessing a rapid uptake of new science.